News
Roche’s IgG2 monoclonal antibody (mAb) astegolimab has yielded mixed results in chronic obstructive pulmonary disease (COPD), ...
The pivotal Phase IIb ALIENTO study met the primary endpoint of a statistically significant reduction in the annualized exacerbation rate (AER) at 52 weeks ...
More women vs. men veterans with COPD received spirometry and tobacco cessation interventions, but more men received correct ...
Poorly controlled asthma often leads to preventable exacerbations that require additional medications, hospital stays, or treatment in the emergency department. Long-acting beta 2 -agonists (LABA) are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results